$1.31
-0.02-1.50%
At close: -
$1.31
0.000200.02%
After Hours: 7:48 PM EDT
Comments
Loading...
Pacific Biosciences Stock Guidance | NASDAQ:PACB | Benzinga
Pacific Biosciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/14/2025 | PACB | Pacific Biosciences | Q4 | 2024 | — | — | — | $39.20M | $39.20M | $40.63M | Get Alert |
| 01/14/2025 | PACB | Pacific Biosciences | FY | 2024 | — | — | — | $154.00M | $154.00M | $155.35M | Get Alert |
| 04/16/2024 | PACB | Pacific Biosciences | FY | 2024 | — | — | — | $170.00M | $200.00M | $238.67M | Get Alert |
| 04/16/2024 | PACB | Pacific Biosciences | Q1 | 2024 | — | — | — | $38.80M | $38.80M | $50.27M | Get Alert |
| 01/08/2024 | PACB | Pacific Biosciences | FY | 2023 | — | — | — | $200.50M | $200.50M | $197.97M | Get Alert |
| 01/08/2024 | PACB | Pacific Biosciences | Q4 | 2023 | — | — | — | $58.40M | $58.40M | $55.82M | Get Alert |
| 01/09/2023 | PACB | Pacific Biosciences | FY | 2022 | — | — | — | $128.20M | $128.20M | $128.97M | Get Alert |
| 01/09/2023 | PACB | Pacific Biosciences | Q4 | 2022 | — | — | — | $27.30M | $27.30M | $27.88M | Get Alert |
| 08/03/2022 | PACB | Pacific Biosciences | FY | 2022 | — | — | — | $138.00M | $145.00M | $161.95M | Get Alert |
| 01/11/2022 | PACB | Pacific Biosciences | Q4 | 2021 | — | — | — | $36.00M | $36.00M | $36.58M | Get Alert |
| 01/11/2022 | PACB | Pacific Biosciences | FY | 2021 | — | — | — | $130.50M | $130.50M | $131.27M | Get Alert |
| 07/20/2021 | PACB | Pacific Biosciences | Q2 | 2021 | — | — | — | $30.50M | $30.50M | $29.89M | Get Alert |
| 01/11/2021 | PACB | Pacific Biosciences | Q4 | 2020 | — | — | — | $27.00M | $27.00M | $23.69M | Get Alert |
FAQ
What is the most recent guidance for Pacific Biosciences (PACB)?
There have been no specific sales or earnings guidance reported for Pacific Biosciences in recent months.
Browse guidance and forecast on all stocks.